retatrutide phase 2 study results trial weight loss Perceived benefits of treatment for obesity with retatrutide: A qualitative of patients in a clinical Phase III retatrutide study demonstrates – The TRIUMPH-1 Phase 3 results

Dosing regimens have ranged from 350 g per week (in vegetarians) to 2000 g per day in a study including patients with pernicious anaemia, with the most common daily dose being 1000 g per day

Among the participants, seven developed non-arteritic ischemic anterior optic neuropathy (NAION), a condition involving sudden and typically permanent vision loss caused by restricted blood flow to the optic nerve

He cited last year's cut of price for his company's insulin as an example of a drug that got dropped by pharmacy benefits managers and is now being discontinued

Pancreatitis during treatment with liraglutide

GLP-1RAs and risk of dementia/stroke/mortality (cohort)

Diet: the keystone of autism spectrum disorder